ORCID Profile
0000-0002-4501-2211
Current Organisations
The University of Auckland
,
Auckland City Hospital
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Wiley
Date: 08-2014
DOI: 10.1111/AJD.12220
Publisher: Elsevier BV
Date: 03-2022
Publisher: Wiley
Date: 08-02-2018
DOI: 10.1111/AJD.12794
Publisher: Wiley
Date: 22-08-2020
DOI: 10.1111/AJD.13142
Publisher: Wiley
Date: 2021
DOI: 10.1111/PDE.14416
Publisher: Wiley
Date: 23-12-2019
DOI: 10.1111/AJD.13220
Publisher: Wiley
Date: 10-09-2020
DOI: 10.1111/AJD.13449
Abstract: Allergic contact dermatitis is a disabling condition, significantly impacting on quality of life, which can only be alleviated by identification and avoidance of a relevant allergen. Patch testing remains the gold standard diagnostic test for allergic contact dermatitis. The consistency with which patch testing is used varies throughout the world. The purpose of this study was to look at the adequacy of current patch testing practice in New Zealand. We undertook literature review of current guidance regarding patch testing and created a web‐based survey to evaluate use of patch testing in New Zealand. This was sent to all 75 vocationally registered New Zealand dermatologists. Of respondents, 46% do not perform patch testing. The most commonly cited barriers were lack of nursing support, poor remuneration, time pressure and lack of facilities. 23% noted that public patch testing services are not available in their region. The majority do not record patch test results in a database. Access to and utilisation of patch testing in New Zealand is suboptimal. Increasing services in the public sector requires investment by health boards, as there remains a dermatology workforce shortage in New Zealand. In private practice, patients often find it unsatisfactory to pay for negative tests, and adequate remuneration of patch testing by private insurers is necessary. Surveillance of patch test results at a national level is lacking, and the development of a centralised database to identify common allergens affecting our population is recommended.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 04-2017
Publisher: Informa UK Limited
Date: 05-2018
DOI: 10.2147/PTT.S141629
Publisher: Wiley
Date: 09-11-2022
DOI: 10.1111/AJD.13745
Publisher: Elsevier BV
Date: 02-2018
DOI: 10.1016/J.JHSA.2017.08.027
Abstract: Neutrophilic dermatosis of the hands is an inflammatory skin condition related to Sweet syndrome that responds to corticosteroids. It commonly affects the dorsum of the hand and often mimics infection, with violaceous inflammatory papules and plaques that may ulcerate. The aim of this study was to review the clinical presentation of neutrophilic dermatosis of the hands. A retrospective review was undertaken of all cases of neutrophilic dermatosis of the hands seen at a tertiary hospital in New South Wales, Australia, over a 5-year period. Seventeen cases were identified. The mean time to diagnosis was 9 days after lesion onset. Most cases were older adults (mean age, 71 years). The most common referral diagnoses were infection or a nonhealing wound and 65% of cases reported a history of trauma. The dorsal index finger was the site of involvement in 41% of cases. One case involved the palm. Histopathology reports were available for skin punch biopsy for 14 of 17 cases, which showed dermal neutrophilic infiltrate (93%) and epidermal involvement with necrosis, ulceration, or pustulation (64%). Six cases were treated surgically prior to the correct diagnosis and management being introduced. Neutrophilic dermatosis of the hands was often misdiagnosed as infection. A history of trauma is common and may be misleading. Dermatological consultation and skin punch biopsy are useful in confirming the diagnosis, ideally prior to surgical management. Diagnostic IV.
No related grants have been discovered for Harriet Kennedy.